~~<i id='721171B898'><strike id='721171B898'><tt id='721171B898'><pre id='721171B898'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

author：focus 2025-09-29 22:38:22 - browse：55

Two Vertex buidings in the Seaport District — David L Ryan/Globe Staff

When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

Now, Vertex may be on the move again.

With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： CDC advisory panel says seniors 'may' get RSV vaccine

hotspot

focus

leisure time

entertainment

explore

Amaskusedinradiationtherapyshowslaserlinesfortargetingcancercellsinthebrain.AdobeEveryyear,doctorsge

WSS

AstraZeneca challenges Medicare drug negotiation program

Australia’s approach to dialysis celebrates life

As pharma fights Medicare drug negotiation, hospitals, docs silent

Xenotransplantation trials will require adjusting expectations, experts say

How Long Island became the ‘eugenics capital of the world’

FDA panel gives mixed vote on blood pressure devices

Wikipedia

Wikipedia

hotspot

Cancer drug shortages should be causing more outrage

AstraZeneca bets AAV gene therapy will still deliver the goods

DIEP, the 'gold standard' of breast reconstruction, is under threat

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Trump demands the U.S. pay no more for drugs than other countries … again

Radiation, mainstay of cancer treatment, begins a fade

Activists slam private health insurers over coverage restrictions

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Feds fine Medicare Advantage plans for overcharging members

focus

Winners, losers from Medicare’s list of drugs subject to price talks

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Patients, doctors are clashing about side effects of hormonal birth control

AstraZeneca challenges Medicare drug negotiation program

FDA approves first new drug developed for postpartum depression

leisure time

entertainment

explore

explore